Cell&Brain Co., Ltd

Global innovative bio technology company leading the development of gene-cell therapy

History

2022

  • 09. Relocation of R&D center
  • 02. Technology transferred (Registered patent on. 10-1850780
    in Industry-Academic Cooperation Foundation of Ajou University)

2021

  • 12. SeriesAFund Raised(5.0 Billion KRW)
  • 08. PCT Application(PCT/KR2021/011553)
  • 06. Extend Venture Company Certification(2021.04 ~ 2024.04)
  • 04. Patent Registration.(10-2247812)
  • 03. Started IIT(Investigator Initiated Trial) for Brain Tumor(GBM)
  • 02. Acquired all technology related Brain Tumor(GBM)Treatment
    from Hanmi Pharm. Co., Ltd.
  • 02. Issue Common Stock(Hanmi Pharm. Co., Ltd)

2020

  • 12. Patent & PCT Application
  • 06. Developed gene integration siteanalyzing pipeline for
    gene transferred stem cell therapy
  • 05. Developed Gene-Stem Cell Therapy platform technology
  • 04. Established branch in Gyeonggi-do
  • 03. Developed lentivirus-based vector manufacturing technology

2019

  • 12. Technology transferred (Registered patent on. 10-1446711
    in academic-industrial cooperation group at Ajou University)
  • 12. New patent application
  • 10. US Patent Prosecution Highway(PPH)
  • 10. Attracted the investment in PreA
  • 08. acquire recognition of a company Research Center
  • 04. Certified as venture company

2018

  • 11. Registered the Research Institute Company
  • 08. Established the department exclusively responsible
    for research and development
  • 07. Signed a contract for a Non-exclusive license agreement with Ajou University
  • 03. Established the company